SCHEMBL3565757

SCHEMBL3565757

OC(c1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 6/20 0.69
KDM4E B2RXH2 7/20 0.53
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
ALDH1A1 P00352 6/20 0.53
GAA P10253 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
HPGD P15428 2/20 0.51
TP53 P04637 1/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
GFER P55789 1/20 0.51
HSD17B10 Q99714 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5677793 0.85 CHEK2 (0.62) CHEK2KDM4ENPC1RAB9AALDH1A1
SCHEMBL5897852 0.84 CHEK2 (0.69) CHEK2KDM4ENPC1RAB9AALDH1A1
SCHEMBL3559427 0.83 CHEK2 (0.70) CHEK2KDM4ENPC1RAB9AALDH1A1
SCHEMBL3572698 0.82 CHEK2 (0.85) CHEK2
SCHEMBL3559345 0.80 KDM4E (0.69) CHEK2KDM4ENPC1RAB9AALDH1A1
SCHEMBL5178716 0.80 CHEK2 (0.65) CHEK2PRMT5
SCHEMBL3333987 0.77 NPC1 (0.68) KDM4ENPC1RAB9AALDH1A1GAA
SCHEMBL3563890 0.76 CHEK2 (0.65) CHEK2KDM4ENPC1RAB9AALDH1A1
SCHEMBL2178266 0.76 NPC1 (0.88) KDM4ENPC1RAB9AALDH1A1GAA
SCHEMBL29386825 0.76 NPC1 (0.88) KDM4ENPC1RAB9AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687639-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-30 US disclosed
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines BW CONVERTING AB (SE) 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDKN1A, DDB1, TMBIM6 CHEK2 14/4885KDM4E 3815/4885NPC1 3612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.